Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).
Roni BittermanFidi KoppelCristina MussiniYuval GeffenMichal ChowersGalia RahavLior NesherRonen Ben-AmiAdi TurjemanMaayan Huberman SamuelMatthew P ChengTodd C LeeLeonard LeiboviciDafna YahavMical PaulPublished in: BMJ open (2021)
ClinicalTrials.gov Registry (NCT03671967); Israeli Ministry of Health Trials Registry (MOH_2018-12-25_004857).